Showing results (81-90 of 103) with videos related to
Sort By:
Pageof 11
Transplantation|April 1, 1991
Serologic and DNA follow-up data from HBsAg-positive patients treated with orthotopic liver transplantationR B Freeman, H Sanchez, W D Lewis, et al.Journal of Chromatography. B, Biomedical Sciences and Applications|June 8, 2001
Measurement of the novel antitumor agent 17-(allylamino)-17-demethoxygeldanamycin in human plasma by high-performance liquid chromatographyE B Agnew, R H Wilson, J L Grem, et al.British Journal of Cancer|August 23, 2007
Sensitivity of epidermal growth factor receptor and ErbB2 exon 20 insertion mutants to Hsp90 inhibitionW Xu, S Soga, K Beebe, et al.Vox Sanguinis|January 1, 1996
Multicenter evaluation of the 3% paraformaldehyde method for white cell counting in leukocyte-reduced red blood cells. BEST (Biomedical Excellence for Safer Transfusion) Working Party of the International Society of Blood TransfusionD Prati, H Brandwein, C Capelli, et al.Biochimica Et Biophysica Acta|March 4, 2000
Nuclear beta-catenin displays GSK-3beta- and APC-independent proteasome sensitivity in melanoma cellsP Bonvini, S G Hwang, M El-Gamil, et al.Oncogene|October 31, 2007
A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasionS Tsutsumi, B Scroggins, F Koga, et al.Cellular and Molecular Biology (Noisy-Le-Grand, France)|April 9, 2002
Lactacystin enhances cisplatin sensitivity in resistant human ovarian cancer cell lines via inhibition of DNA repair and ERCC-1 expressionQ Q Li, M K Yunmbam, X Zhong, et al.Current Topics in Medicinal Chemistry|October 29, 2009
Update on Hsp90 inhibitors in clinical trialY S Kim, S V Alarcon, S Lee, et al.FEBS Letters|October 19, 1987
Site-selective cyclic AMP analogs provide a new approach in the control of cancer cell growthD Katsaros, G Tortora, P Tagliaferri, et al.Biochemical Pharmacology|September 29, 2000
Prevention of cisplatin-DNA adduct repair and potentiation of cisplatin-induced apoptosis in ovarian carcinoma cells by proteasome inhibitorsE G Mimnaugh, M K Yunmbam, Q Li, et al.Pageof 11